Melinda Peters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Melinda Peters has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anjanet Loon
Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, USA
1 shared publication - Awa Sanneh
Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, USA
1 shared publication - Breanna Brown
Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, USA
1 shared publication - Daniel C. Lee
Sanders-Brown Center on Aging (SBCoA), College of Medicine, University of Kentucky, 800 S. Limestone St., Lexington, KY, 40536, USA.
1 shared publication - Dave Morgan
Department of Molecular Pharmacological & Physiology, Morsani College of Medicine, University of South Florida, Tampa, USA
1 shared publication - Edwin John Weeber
University of South Florida
1 shared publication
Latest Publications
- 19 August 2021
- Published by Springer Nature in GeroScience
- Vol. 44 (1) , 173-194
Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice
C-terminal cleaved tau at D421 (∆D421-tau) accumulates in the brains of Alzheimer’s disease (AD) patients. However, it is unclear how tau truncation, an understudied tau post-translational modification, contributes to AD pathology and progression. Utilizing an adeno-associated virus (AAV) gene delivery-based approach, we overexpressed full-length tau (FL-tau) and ∆D421-tau in 4- and 12-month-old mice for 4 months to study the neuropathological impact of accumulation in young adult (8-month) and middle-aged (16-month) mice. Overall, we show that independent of the tau species, age was an important factor facilitating tau phosphorylation, oligomer formation, and deposition into silver-positive tangles. However, mice overexpressing ∆D421-tau exhibited a distinct phosphorylation profile to those overexpressing FL-tau and increased tau oligomerization in the middle-age group. Importantly, overexpression of ∆D421-tau, but not FL-tau in middle-aged mice, resulted in pronounced cognitive impairments and hippocampal long-term potentiation deficits. While both FL-tau and ∆D421-tau induced neuronal loss in mice with age, ∆D421-tau led to significant neuronal loss in the CA3 area of the hippocampus and medial entorhinal cortex compared to FL-tau. Based on our data, we conclude that age increases the susceptibility to neuronal degeneration associated with ΔD421-tau accumulation. Our findings suggest that ΔD421-tau accumulation contributes to synaptic plasticity and cognitive deficits, thus representing a potential target for tau-associated pathologies.
- 19 August 2021
- Published by Springer Nature in GeroScience
- Vol. 44 (1) , 173-194
Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice
C-terminal cleaved tau at D421 (∆D421-tau) accumulates in the brains of Alzheimer’s disease (AD) patients. However, it is unclear how tau truncation, an understudied tau post-translational modification, contributes to AD pathology and progression. Utilizing an adeno-associated virus (AAV) gene delivery-based approach, we overexpressed full-length tau (FL-tau) and ∆D421-tau in 4- and 12-month-old mice for 4 months to study the neuropathological impact of accumulation in young adult (8-month) and middle-aged (16-month) mice. Overall, we show that independent of the tau species, age was an important factor facilitating tau phosphorylation, oligomer formation, and deposition into silver-positive tangles. However, mice overexpressing ∆D421-tau exhibited a distinct phosphorylation profile to those overexpressing FL-tau and increased tau oligomerization in the middle-age group. Importantly, overexpression of ∆D421-tau, but not FL-tau in middle-aged mice, resulted in pronounced cognitive impairments and hippocampal long-term potentiation deficits. While both FL-tau and ∆D421-tau induced neuronal loss in mice with age, ∆D421-tau led to significant neuronal loss in the CA3 area of the hippocampus and medial entorhinal cortex compared to FL-tau. Based on our data, we conclude that age increases the susceptibility to neuronal degeneration associated with ΔD421-tau accumulation. Our findings suggest that ΔD421-tau accumulation contributes to synaptic plasticity and cognitive deficits, thus representing a potential target for tau-associated pathologies.